Notes
The study was partially supported by Novartis Pharmaceutical, S.A.
Reference
Gracia F, et al. Costs of multiple sclerosis in Panama from societal, patient perspectives and health-related quality of life. PLOS One : 10 Oct 2018. Available from: URL: https://doi.org/10.1371/journal.pone.0204681
Rights and permissions
About this article
Cite this article
MS substantial economic burden for patients and society in Panama. PharmacoEcon Outcomes News 814, 18 (2018). https://doi.org/10.1007/s40274-018-5361-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5361-9